1780TiP A phase II clinical study to assess efficacy of induction ipilimumab/nivolumab to spare the bladder in urothelial bladder cancer (INDI-BLADE).
Saved in:
| Title: | 1780TiP A phase II clinical study to assess efficacy of induction ipilimumab/nivolumab to spare the bladder in urothelial bladder cancer (INDI-BLADE). |
|---|---|
| Authors: | Stockem, C.F.1 (AUTHOR), van Rhijn, B.W.G.2 (AUTHOR), Boellaard, T.3 (AUTHOR), van Montfoort, M.L.4 (AUTHOR), Balduzzi, S.5 (AUTHOR), Boormans, J.6 (AUTHOR), Franckena, M.7 (AUTHOR), Meijer, R.8 (AUTHOR), Noteboom, J.9 (AUTHOR), Robbrecht, D.10 (AUTHOR), Suelmann, B.B.11 (AUTHOR), Schaake, E.12 (AUTHOR), van der Heijden, M.S.13 (AUTHOR) |
| Source: | Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1351-S1351. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2022.07.1939 |
